background

WHY CHOOSE PURAPLY® AM
& PURAPLY® XT

POWER OF PLUS WITH PURAPLY® AM & PURAPLY® XT

Native, cross-linked extracellular matrix scaffold + sustained antimicrobial effectiveness within the product to support wound healing and granulation tissue formation.1-6

PURAPLY® AM &
PURAPLY® XT Overview

Take control before biofilm re-forms. Use PuraPly® AM and PuraPly® XT.

Native ECM scaffold + broad-spectrum PHMB antimicrobial for next-level wound healing support.1-3,5

LEARN MORE>
Power Plus Illustration
For wound
care centersDOWNLOAD
For physician
officesDOWNLOAD

PURAPLY® AM
& PURAPLY® XT
Product details

See resources for PuraPly® AM and PuraPly® XT, including available product sizes and the wound types they can manage.

LEARN MORE>
PuraPly® AM <br /> wound care <br /> centers
PuraPly® AM
wound care
centersDOWNLOAD
PuraPly® AM <br /> physician offices
PuraPly® AM
physician officesDOWNLOAD
Puraply® XT
Puraply® XTDOWNLOAD

EXPANDING EVIDENCE BASE

Discover the scientific and real-world evidence that demonstrates the effectiveness of PuraPly® AM and PuraPly® XT, when used as antimicrobial barriers3,4.

LEARN MORE>

READY TO LEARN MORE HOW PURAPLY AM & PURAPLY XT HELP SUPPORT HEALING?

Contact an Organogenesis Tissue Regeneration Specialist to see how PuraPly® AM and PuraPly® XT can help your patients.

Please refer to the PuraPly AM Instructions for Use and
PuraPly XT Instructions for Use for complete prescribing information.

References:

1. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc; 2023. 2. PuraPly XT [package insert]. Canton, MA: Organogenesis Inc; 2023. 4. Davis SC, et al. Int Wound J.2022;19(1):86-99. 5. Data on file. PDR-0008. Organogenesis Inc. 6.Gilbert P, et al. J Appl Microbiol. 2005;99(4):703-715. 7. Carpenter S, et al. Wounds. 2016;28(6 suppl):S1-S20. 8. Data on file. PDR-0007. Organogenesis Inc. 9. Data on file. PDR-0005. Organogenesis Inc. 10. Khor E. Biomaterials. 1997;18(2):95-105. 11. Billiar K, et al. J Biomed Mater Res.2001;56(1):101-108. 12. Brett D. Wounds. 2008;20(12):347-356. 13.Hübner NO, Kramer A. Skin Pharmacol Physiol. 2010;23(suppl):17-27.